FDA Approves ILUMYA for Adults With Active Psoriatic Arthritis
Paul Pickrell, MD, and Tekton’s Austin team supported INSPIRE 1, one of the Phase 3 studies behind ILUMYA’s new approval for active psoriatic arthritis.
Paul Pickrell, MD, and Tekton’s Austin team supported INSPIRE 1, one of the Phase 3 studies behind ILUMYA’s new approval for active psoriatic arthritis.
Stefanie Hunter, VP, Patient Strategy, shares what she’s learned about recruitment, earning trust, showing up in the community, and listening to participants.
Tekton is introducing its Alzheimer’s Team, bringing together practicing physician-investigators, experienced neuroscience raters, and clinical and operational leaders to advance research across six lead sites. The team’s focus includes Alzheimer’s disease, mild cognitive impairment (MCI), and agitation associated with Alzheimer’s disease. Its clinical expertise spans memory loss, dementia, geriatric psychiatry, and related conditions. For Sponsors … Read more
In the Society for Clinical Research Sites (SCRS) webinar, “The Physician-Led Advantage: Strengthening Site-Sponsor-CRO Partnerships,” Jara McDonald, MD, FAAFP, DABOM, CPI, Tekton’s Executive Medical Director and Cardiometabolic Research Lead, shared practical lessons on physician engagement and collaboration across clinical research. Watch the full webinar on YouTube > The full recording is now available on YouTube. … Read more
Celebrating a job well done by Ernest Graypel, MD, MHA, Brandon Lenfest, Mejra Dzinic, and our St. Louis team! After joining an Alzheimer’s trial as a rescue site, the team exceeded its enrollment goal. Thank you for the hard work behind this accomplishment!
Tekton Research, a multi-specialty clinical research site organization, has hired three vice presidents to lead its neuroscience, cardiometabolic, and endocrinology research operations, and to advance its patient engagement strategy. All three began their careers working inside research sites. Patricia Brown, PhD, APRN, joins as Vice President, Clinical Operations, Neuroscience. Brown has worked on both the … Read more
Tekton has introduced the Tekton Psychiatry Team, bringing together physician-investigators and operational leaders to provide centralized expertise for mental and behavioral health studies across 17 Tekton sites. From protocol review and rater consistency to participant engagement and staff mentorship, the team strengthens how Tekton sites support mood, anxiety, addiction, and behavioral health research. The Psychiatry Team … Read more
Tekton Research’s San Antonio, TX, and Edmond, OK, teams achieved 300% of their combined initial enrollment goal for a recent Phase 2 obesity trial, randomizing 60 participants against a target of 20. Congratulations to: Jara McDonald, MD, FAAFP, DABOM, CPI, Evelyn Guajardo, and our San Antonio team Kyle Rickner, MD, Bettina Beard, and our Edmond … Read more
Tekton Research is proud to congratulate Marlee Sanchez, Clinical Research Coordinator III in Fort Collins, CO, on being named a finalist for the first-ever SCRS Next Up Award. Marlee brings care and a collaborative spirit to her work, guiding participants through complex studies, mentoring colleagues, and helping Tekton’s sites across Colorado and beyond work as … Read more
Brian Bailey, MSBS-MS, is Tekton’s Clinical Compliance and Operations Director, based in Austin, Texas. He oversees site-level investigational product (IP) management and helps set compliance and operations processes companywide. We spoke with him about his Navy and surgical background, improving temperature-alert response across Tekton, and what Sponsors and CROs can do to make IP management … Read more